Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Case Report
2020:86:4;382-385
doi: 10.4103/ijdvl.IJDVL_633_17
PMID: 30785120

Pseudoxanthomatous or xanthelasmoid mastocytosis: Reporting a rare entity

Preema Sinha, Sunmeet Sandhu, Arijit Sen, Aradhana Sood
 Department of Dermatology, Armed Forces Medical College, Pune, Maharashtra, India

Correspondence Address:
Preema Sinha
Department of Dermatology, Armed Forces Medical College, Pune - 411 040, Maharashtra
India
Published: 15-Feb-2019
How to cite this article:
Sinha P, Sandhu S, Sen A, Sood A. Pseudoxanthomatous or xanthelasmoid mastocytosis: Reporting a rare entity. Indian J Dermatol Venereol Leprol 2020;86:382-385
Copyright: (C)2020 Indian Journal of Dermatology, Venereology, and Leprology

Abstract


Mastocytosis is a disease characterized by abnormal and pathologic increase in mast cells in the cutaneous tissue and extracutaneous organs such as the bone marrow, liver, spleen, lymph node and gastrointestinal tract. Cutaneous mastocytosis comprises of four major clinical variants: solitary and multiple mastocytomas, urticaria pigmentosa, diffuse cutaneous mastocytosis and telangiectasia macularis eruptiva perstans. Cutaneous mastocytosis of the xanthelasmoid type is a rare variant of diffuse mastocytosis. It is clinically characterized by the typical yellowish hue and is accompanied histologically by mast cells infiltrating far into the lower dermis. Here we report one such rare case.
Keywords: Diffuse cutaneous mastocytosis, rare, xanthelasmoid variant

Introduction

Mastocytosis is a rare disease characterized by a primary pathological increase in the number of mast cells. These disorders present with varied clinical signs, symptoms and prognosis. The skin is the most commonly involved organ in all types of mastocytosis. Diffuse cutaneous mastocytosis is an extremely rare form of mastocytosis in which mast cells infiltrate the entire skin diffusely. Patients with this type of mastocytosis are at risk of systemic disease and severe complications but it often resolves spontaneously as in other types of childhood disease.[1],[2]

Case Report

An 11-year-old boy, born out of nonconsanguineous marriage presented with multiple raised pruritic yellowish to skin colored eruptions over the trunk and extremities, involving more than 70% of the body surface area for the past 2 years. Pruritus was severe enough to disturb his sleep. The child was delivered at an institution by vaginal route with an uneventful perinatal period and was exclusively breastfed with immunization up-to-date. There was a significant past history of recurrent episodes of vesiculo-bullous eruptions over the body since 11 months of age, which was managed at a government hospital till the age of 5 years. The vesiculo-bullous lesions were extremely pruritic and with symptomatic management had subsided by 5 years of age. The child was developmentally normal.

Examination revealed an averagely built boy at par with his age with no systemic abnormalities. Dermatological examination revealed multiple discrete to confluent yellowish papules and plaques predominantly over the trunk and also involving all four extremities with a rubbery consistency [Figure - 1]. The Darier's sign was negative.

Figure 1: Multiple discrete to confluent yellowish papules and plaques over trunk with a rubbery consistency

Hematological, biochemical and urine analysis were within normal limits. Skin biopsy from the trunk revealed thinned out epidermis. Collection of mast cells in cords and nests was seen in both papillary and reticular dermis with many cells aggregated around the blood vessels [Figure - 2] and [Figure - 3]. These cells were monomorphic with abundant dense eosinophilic granular cytoplasm and dense round to eccentric nuclei. No involvement of deep reticular dermis was seen. Toluidine blue stain highlighted the dermal collection of mast cells [Figure - 4]. Immunohistochemistry was positive for CD 117, whereas negative for pan CK [Figure - 5]. Evaluation for any systemic involvement in the form of bone marrow studies was normal with 3% (mild) increase in mast cells. Serum tryptase level was 8 ng/ml. Based on the clinical, histopathological and immunohistochemical studies, he was diagnosed as a case of xanthelasmoid variant of diffuse cutaneous mastocytosis.

Figure 2: Collection of mast cells in cords and nests in dermis [hematoxylin and eosin (H and E), ×100]
Figure 3: High power view of mast cells in dermis (H and E, ×400)
Figure 4: Stain highlighted the metachromatic staining of mast cells (toluidine blue, ×400)
Figure 5: Immunohistochemistry stain showed mast cells positive for CD 117 (immunohistochemistry, ×400)

The child was managed symptomatically with oral antihistamines and topical emollients. The parents were counseled regarding the course and the outcome of the disease and avoidance of certain triggering factors including some drugs that may lead to mast cell degranulation and thereby flaring of the skin lesions. The patient has been under follow-up for the last 6 months with no fresh symptoms or signs.

Discussion

Mastocytosis is a disease characterized by abnormal and pathologic increase in mast cells in the cutaneous tissue and extracutaneous organs such as the bone marrow, liver, spleen, lymph node and gastrointestinal tract.[1] Mastocytosis is classified into three major clinical types: cutaneous, systemic and malignant forms. Cutaneous mastocytosis is a heterogeneous disorder that has the following major variants: urticaria pigmentosa, diffuse cutaneous mastocytosis, mastocytoma and telangiectasia macularis eruptiva perstans.[2]

Despite varied clinical features, the histological hallmark is the same for all types of cutaneous lesions with diffuse infiltration of mast cell in the dermis. The prognosis is good, but there is a risk of sudden mast cell degranulation due to any trigger and subsequent collapse. The most affected age group is <15 years with onset in infancy with a slight male to female predominance (1.5:1). Local and systemic symptoms in mastocytosis are caused by excessive production of mast cell- mediators such as histamine, leukotrienes, proteases and heparin.[3] The symptoms vary from patient to patient and include pruritus, dyspnea, flushing, blistering, bone pain, and features of gastrointestinal involvement in the form of vomiting, diarrhea and epigastric pain.[3],[4]

Diffuse cutaneous mastocytosis has two clinical variants: pseudoxanthomatous or xanthelasmoid and bullous type. Diffuse cutaneous mastocytosis is the rarest subtype, accounting for only 1.74% of all cases of cutaneous mastocytosis.[5] Diffuse cutaneous mastocytosis may present as a diffuse reddish-brown discoloration with a peau d'orange appearance affecting the entire surface of the skin, along with multiple yellowish or brownish doughy nodules resembling xanthomas or lesions of pseudoxanthoma elasticum, and is termed pseudoxanthomatous or xanthelasmoid mastocytosis. The exact prevalence of xanthelasmoid variant is not known but can vary from 8 to 25%.[6] Sometimes this variant has been accompanied by urticaria pigmentosa and juvenile xanthogranuloma.[7]

In patients with diffuse cutaneous mastocytosis, the first sign may be extensive bullae which may rupture, leaving erosions and crusts. The blisters may be of various sizes, initially contain clear fluid that may become hemorrhagic with time. Bullous lesions may occur in linear or grouped fashion and often develop on the trunk, scalp and extremities. These lesions typically resolve by 3–5 years of age without scarring. The blisters are believed to be caused by serine proteases that are released from the mast cells.[8]

Diffuse cutaneous mastocytosis can involve the entire skin with the central region and scalp most affected. The skin may be leathery and thickened. Hyperpigmentation may persist into adulthood and dermatographism may be prominent. Depending on the extent of the lesions and their severity, systemic symptoms can be present due to the large amount of mast cell mediators released locally and absorbed locally and systemically. Whole body flushing, pruritus, diarrhea, intestinal bleeding, hypotension, anemia, hypovolemic shock and deaths have been reported.[8] Visceral involvement with lymphadenopathy and hepatomegaly may be present. A rare complication includes pachydermia.[9] This form is particularly sensitive to psoralen-ultraviolet A with some reports of total or partial resolution after psoralen-ultraviolet A.

Pathogenesis of pediatric mastocytosis is different from the adult type. In adults there is a genetic inactivating mutation of the growth factor receptor c-kit. This mutation is absent in the pediatric cases which may explain the transient nature of the disease in them in comparison to adults.[9] However, children with progressive mastocytosis may express the same mutation as adults. Overall childhood mastocytosis has a good prognosis, but sometimes it can be progressive and fatal.

A study by Kettelhut et al. revealed that in most cases cutaneous mastocytosis in children does not involve internal organs which precludes the need for routine prognostic bone marrow biopsies.[10] Serum tryptase was significantly elevated only in children with systemic disease.[11]

Thus, cutaneous mastocytosis is a heterogeneous disease where neither the extent or the nature of skin lesions can predict the presence of systemic involvement. A better understanding of the pathogenesis would go a long way in understanding the disease.

One of the major concerns about diffuse cutaneous mastocytosis in pediatric patients is its association with systemic symptoms, such as debilitating diarrhea, gastrointestinal manifestations, shock and hypotension because of the much higher concentration of mast cells. However, in our patient, no systemic symptoms were observed during the hospital stay and inpatient visits.[6] Hence this case is being reported because of its rarity.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the parent has given the consent for images and other clinical information to be reported in the journal. The parent understands that names and initials will not be published and due efforts will be made to conceal patient identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Weedon D. Cutaneous infiltrates-non-lymphoid. In: Skin Pathology. 2nd ed. London: Churchill Livingstone; 2002. p. 1057-93.
[Google Scholar]
2.
Husak R, Blume-Peytavi U, Pfrommer C, Geilen CC, Goerdt S, Orfanos CE. Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type: Case report. Br J Dermatol 2001;144:355-8.
[Google Scholar]
3.
Nayak S, Acharjya B, Devi B, Behera SK. Bullous mastocytosis. Indian J Dermatol 2007;52:201-3.
[Google Scholar]
4.
Hartmann K, Henz BM. Mastocytosis: Recent advances in defining the disease. Br J Dermatol 2001;144:682-95.
[Google Scholar]
5.
Fernandez AT, Campoamor LN, Mora LE, Zambrano AZ. Diagnosis, management and classification of pediatric mastocytosis. A study of 172 cases. Actas Dermosifiliogr 1998;89:461-76.
[Google Scholar]
6.
Nabavi NS, Nejad MH, Feli S, Bakhshoodeh B, Layegh P. Adult onset of xanthelasmoid mastocytosis: Report of a rare entity. Indian J Dermatol 2016;61:468.
[Google Scholar]
7.
De Villez RL, Limmer BL. Juvenile xanthogranuloma and urticaria pigmentosa. Arch Dermatol 1975;111:365-6.
[Google Scholar]
8.
Hartmann K, Metcalfe DD. Pediatric mastocytosis. Hematol Oncol Clin North Am 2000;14:625-40.
[Google Scholar]
9.
Walker T, von Komorowski G, Scheurlen W, Dorn-Beineke A, Back W, Bayerl C. Neonatal mastocytosis with pachydermic bullous skin without c-kit 816 mutation. Dermatology 2006;212:70-2.
[Google Scholar]
10.
Kettelhut BV, Parker RI, Travis WD, Metcalfe DD. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients. Am J Clin Pathol 1989;91:558-62.
[Google Scholar]
11.
Brockow K, Akin C, Huber M, Metcalfe DD. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003;48:508-16.
[Google Scholar]

Fulltext Views
554

PDF downloads
174
Show Sections